PPA
ACET icon

Parametric Portfolio Associates’s Adicet Bio ACET Stock Holding History

Parametric Portfolio Associates’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$430K Sell
1,347
-11
-0.8% -$2.53K ﹤0.01% 3158
2021
Q4 		$380K Buy
1,358
+278
+26% +$47.7K ﹤0.01% 3179
2021
Q3 		$136K Buy
+1,080
New +$134K ﹤0.01% 3495
2020
Q3 		– Sell
-224
Closed -$54K – 3922
2020
Q2 		$54K Buy
+224
New +$44K ﹤0.01% 3855
2019
Q4 		– Sell
-119
Closed -$118K – 3956
2019
Q3 		$118K Sell
119
-9
-7% -$10K ﹤0.01% 3808
2019
Q2 		$146K Buy
+128
New +$116K ﹤0.01% 3797

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Parametric Portfolio Associates's ACET Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Adicet Bio (ACET) stake by 0.81% in Q1 2022, selling an estimated $2.53K and leaving 1,347 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Parametric Portfolio Associates first reported a position in ACET in Q2 2019 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold ACET as of Q1 2022.

  • Parametric Portfolio Associates held 1,347 shares of Adicet Bio worth $430K as of Q1 2022.
  • Parametric Portfolio Associates sold 11 Adicet Bio shares in Q1 2022, an estimated $2.53K.
  • Adicet Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3158 holding.
  • Parametric Portfolio Associates first reported a position in Adicet Bio in Q2 2019 and has held it in 6 quarters since.
  • 87 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.